Kevin R. Lind

2022 - Longboard Pharmaceuticals

In 2022, Kevin R. Lind earned a total compensation of $1.5M as President and Chief Executive Officer at Longboard Pharmaceuticals, a 72% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$377,520
Option Awards$544,070
Salary$572,000
Other$12,325
Total$1,505,915

Lind received $572K in salary, accounting for 38% of the total pay in 2022.

Lind also received $377.5K in non-equity incentive plan, $544.1K in option awards and $12.3K in other compensation.

Rankings

In 2022, Kevin R. Lind's compensation ranked 2,217th out of 5,676 executives tracked by ExecPay. In other words, Lind earned more than 60.9% of executives.

ClassificationRankingPercentile
All
2,217
out of 5,676
61st
Division
Manufacturing
1,198
out of 3,084
61st
Major group
Chemicals And Allied Products
523
out of 1,399
63rd
Industry group
Drugs
481
out of 1,300
63rd
Industry
Pharmaceutical Preparations
347
out of 942
63rd
Source: SEC filing on April 11, 2023.

Lind's colleagues

We found two more compensation records of executives who worked with Kevin R. Lind at Longboard Pharmaceuticals in 2022.

2022

Randall Kaye

Longboard Pharmaceuticals

Chief Medical Officer

2022

Brandi Roberts

Longboard Pharmaceuticals

Chief Financial Officer

News

You may also like